Avelumab for metastatic Merkel cell carcinoma after chemotherapy
Avelumab for metastatic Merkel cell carcinoma after chemotherapy
Nivolumab and ipilimumab combination for advanced skin cancer
Long-term clinical outcomes and analyses of atezolizumab for mTNBC
Checkmate 067 - combined nivolumab and ipilimumab
Glycemia positively associated with prostate cancer mortality in non-diabetic men
IDH metabolites induce a BRCAness that can be exploited by PARP inhibitors
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses
Five-year follow-up of nivolumab in NSCLC
Mutations in cancer predisposition genes and risk for subsequent neoplasms
Treatment choices for HER2 amplified colorectal cancer
Final results of the HERACLES trial in HER2-amplified colorectal cancer
Understanding response and resistance to cancer therapy: Lessons learned from melanoma